Advances in organ-specific cancer research have significantly enhanced our understanding of cancer's unique biology and progression within different organs. Researchers are now focusing on how cancer cells behave differently in various tissues, which has led to more targeted therapies and personalized treatment plans. For instance, breakthroughs in breast cancer research have highlighted the role of specific genetic mutations in tumor development, allowing for therapies that target those mutations. Similarly, liver cancer research has uncovered the role of the liver's microenvironment in cancer growth, paving the way for treatments that disrupt these interactions. Advances in imaging technologies and biomarker identification have also allowed for earlier detection, improving prognosis and treatment outcomes. With ongoing progress in molecular profiling and organ-specific models, these advances are paving the way for more effective, tailored therapies, offering hope for improved survival rates across multiple cancer types.
Title : RNA binding proteins in the pathogenesis of pediatric cancer
Atif A Ahmed, University of Washington-Seattle Children’s Hospital, United States
Title : A novel mRNA genomic technology for precision medicine, early cancer diagnosis, prognosis, treatment follow-up and cancer gene therapy
Rajvir Dahiya, University of California San Francisco, United States
Title :
Jianhua Luo, University of Pittsburgh, United States
Title : Biosensor-based detection of cancer biomarkers
Michael Thompson, University of Toronto, Canada
Title : Principles of oral rehabilitation in H&N cancer patients
Pietro Salvatori, Independent H&N Surgeon, Italy
Title :
Marika Crohns, Impactful Innovations Management Consultants LLC, United Arab Emirates